Wordt geladen...

Novel Oral Anticoagulants Versus Warfarin Therapy at Various Levels of Anticoagulation Control in Atrial Fibrillation—A Cost-Effectiveness Analysis

BACKGROUND: The decision as to whether to use more expensive novel oral anticoagulants (NOACs) or invest resources for quality improvement of warfarin therapy requires input from both clinical and economic analyses. OBJECTIVE: Cost-effectiveness of NOACs compared to warfarin therapy at various level...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: You, Joyce H. S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer US 2013
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3930767/
https://ncbi.nlm.nih.gov/pubmed/24132628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11606-013-2639-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!